Yes, administer aspirin 162-325 mg immediately, even if the patient is already on DAPT.
In patients with suspected acute coronary syndrome, a loading dose of non-enteric-coated, chewable aspirin (162-325 mg) should be administered as soon as possible upon presentation, regardless of whether they are already taking aspirin or dual antiplatelet therapy at home. 1, 2
Rationale for Loading Dose Administration
The guidelines are unequivocal on this point: aspirin loading should occur "as soon as possible after presentation" for all patients with suspected ACS without contraindications 1. This recommendation holds a Class I, Level of Evidence A designation across multiple major guidelines 3, 1, 4, 2.
Why Give Aspirin Even If Already on DAPT?
- Immediate platelet inhibition is critical: The loading dose ensures rapid and complete platelet inhibition at the time of acute thrombotic event, which may not be adequately achieved by maintenance doses alone
- Uncertain adherence: You cannot be certain the patient has been compliant with their home medications
- Timing matters: The patient's last dose timing is often unknown, and therapeutic levels may not be present
- Guideline consistency: All major guidelines (AHA/ACC 2014,2015,2025) recommend loading dose administration "to all patients" without exception for those already on therapy 1, 2
Practical Implementation
Dosing specifics:
- Loading dose: 162-325 mg non-enteric-coated, chewable aspirin 1, 2
- Timing: Administer immediately upon suspicion of ACS, before diagnostic confirmation
- Route: Oral (chewed) is preferred; rectal or IV (where available) if patient cannot take oral 2
- Maintenance: Continue 81-325 mg daily indefinitely (81 mg preferred, especially with ticagrelor) 1, 2
Important Caveats
Absolute contraindications:
- Active bleeding or recent major gastrointestinal bleeding 3, 4
- Known aspirin hypersensitivity (consider desensitization if possible) 2
Key pitfall to avoid: Do NOT use enteric-coated aspirin initially—it has delayed and reduced absorption 1. The patient should chew the aspirin for fastest absorption.
P2Y12 Inhibitor Management
If the patient is already on a P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel), continue it and consider whether switching to a more potent agent is appropriate based on their presentation:
- For NSTE-ACS or STEMI: Ticagrelor (180 mg load, 90 mg BID) is preferred over clopidogrel 1, 5
- For STEMI undergoing immediate PCI: Prasugrel (60 mg load, 10 mg daily) may be used if no prior stroke/TIA 1, 6, 5
- If already on ticagrelor or prasugrel at therapeutic doses, switching is generally not necessary 5
The aspirin loading dose should be given regardless of P2Y12 inhibitor status 1, 2.